The role of RNA methylation in glioma progression: mechanisms, diagnostic implications, and therapeutic value

Glioma represents a highly lethal form of malignant tumour, with RNA methylation emerging as a critical regulator of its oncogenesis and progression. As a prevalent post-translational modification, methylation influences various biological functions, particularly RNA processing, by modulating splici...

Full description

Saved in:
Bibliographic Details
Main Authors: Shao-Ze Zhang, Shao-Yan Liu, Meng-Die Cheng, Yin-Feng Zhang, Jia-Wei Tian
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1583039/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850128442091110400
author Shao-Ze Zhang
Shao-Ze Zhang
Shao-Ze Zhang
Shao-Yan Liu
Meng-Die Cheng
Yin-Feng Zhang
Jia-Wei Tian
author_facet Shao-Ze Zhang
Shao-Ze Zhang
Shao-Ze Zhang
Shao-Yan Liu
Meng-Die Cheng
Yin-Feng Zhang
Jia-Wei Tian
author_sort Shao-Ze Zhang
collection DOAJ
description Glioma represents a highly lethal form of malignant tumour, with RNA methylation emerging as a critical regulator of its oncogenesis and progression. As a prevalent post-translational modification, methylation influences various biological functions, particularly RNA processing, by modulating splicing, transport, and degradation of both mRNAs and noncoding RNAs. Key methylation types such as N6-methyladenosine (m6A), N5-methylcytosine (m5C), N7-methylguanosine (m7G), and N1-methyladenosine (m1A) are dynamically regulated by specific enzymes known as writers, erasers, and readers. Dysregulation of these modifications contributes to glioma pathophysiology, while offering potential biomarkers for early detection and promising therapeutic targets. This review explores the mechanistic roles of RNA methylation in glioma and highlights its translational implications, aiming to advance molecular diagnostics and targeted interventions in glioma treatment.
format Article
id doaj-art-ad664e5e8f9e4dc5a56a010d6583db22
institution OA Journals
issn 1664-3224
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-ad664e5e8f9e4dc5a56a010d6583db222025-08-20T02:33:18ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-05-011610.3389/fimmu.2025.15830391583039The role of RNA methylation in glioma progression: mechanisms, diagnostic implications, and therapeutic valueShao-Ze Zhang0Shao-Ze Zhang1Shao-Ze Zhang2Shao-Yan Liu3Meng-Die Cheng4Yin-Feng Zhang5Jia-Wei Tian6Department of Emergency Internal Medicine, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, Shandong, ChinaInstitute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, ChinaDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Hospital Infection of Management Department, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, ChinaDepartment of Emergency Internal Medicine, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, Shandong, ChinaInstitute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, ChinaDepartment of Emergency Internal Medicine, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, Shandong, ChinaGlioma represents a highly lethal form of malignant tumour, with RNA methylation emerging as a critical regulator of its oncogenesis and progression. As a prevalent post-translational modification, methylation influences various biological functions, particularly RNA processing, by modulating splicing, transport, and degradation of both mRNAs and noncoding RNAs. Key methylation types such as N6-methyladenosine (m6A), N5-methylcytosine (m5C), N7-methylguanosine (m7G), and N1-methyladenosine (m1A) are dynamically regulated by specific enzymes known as writers, erasers, and readers. Dysregulation of these modifications contributes to glioma pathophysiology, while offering potential biomarkers for early detection and promising therapeutic targets. This review explores the mechanistic roles of RNA methylation in glioma and highlights its translational implications, aiming to advance molecular diagnostics and targeted interventions in glioma treatment.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1583039/fullepitranscriptomeM6Am5Cm7Gm1A
spellingShingle Shao-Ze Zhang
Shao-Ze Zhang
Shao-Ze Zhang
Shao-Yan Liu
Meng-Die Cheng
Yin-Feng Zhang
Jia-Wei Tian
The role of RNA methylation in glioma progression: mechanisms, diagnostic implications, and therapeutic value
Frontiers in Immunology
epitranscriptome
M6A
m5C
m7G
m1A
title The role of RNA methylation in glioma progression: mechanisms, diagnostic implications, and therapeutic value
title_full The role of RNA methylation in glioma progression: mechanisms, diagnostic implications, and therapeutic value
title_fullStr The role of RNA methylation in glioma progression: mechanisms, diagnostic implications, and therapeutic value
title_full_unstemmed The role of RNA methylation in glioma progression: mechanisms, diagnostic implications, and therapeutic value
title_short The role of RNA methylation in glioma progression: mechanisms, diagnostic implications, and therapeutic value
title_sort role of rna methylation in glioma progression mechanisms diagnostic implications and therapeutic value
topic epitranscriptome
M6A
m5C
m7G
m1A
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1583039/full
work_keys_str_mv AT shaozezhang theroleofrnamethylationingliomaprogressionmechanismsdiagnosticimplicationsandtherapeuticvalue
AT shaozezhang theroleofrnamethylationingliomaprogressionmechanismsdiagnosticimplicationsandtherapeuticvalue
AT shaozezhang theroleofrnamethylationingliomaprogressionmechanismsdiagnosticimplicationsandtherapeuticvalue
AT shaoyanliu theroleofrnamethylationingliomaprogressionmechanismsdiagnosticimplicationsandtherapeuticvalue
AT mengdiecheng theroleofrnamethylationingliomaprogressionmechanismsdiagnosticimplicationsandtherapeuticvalue
AT yinfengzhang theroleofrnamethylationingliomaprogressionmechanismsdiagnosticimplicationsandtherapeuticvalue
AT jiaweitian theroleofrnamethylationingliomaprogressionmechanismsdiagnosticimplicationsandtherapeuticvalue
AT shaozezhang roleofrnamethylationingliomaprogressionmechanismsdiagnosticimplicationsandtherapeuticvalue
AT shaozezhang roleofrnamethylationingliomaprogressionmechanismsdiagnosticimplicationsandtherapeuticvalue
AT shaozezhang roleofrnamethylationingliomaprogressionmechanismsdiagnosticimplicationsandtherapeuticvalue
AT shaoyanliu roleofrnamethylationingliomaprogressionmechanismsdiagnosticimplicationsandtherapeuticvalue
AT mengdiecheng roleofrnamethylationingliomaprogressionmechanismsdiagnosticimplicationsandtherapeuticvalue
AT yinfengzhang roleofrnamethylationingliomaprogressionmechanismsdiagnosticimplicationsandtherapeuticvalue
AT jiaweitian roleofrnamethylationingliomaprogressionmechanismsdiagnosticimplicationsandtherapeuticvalue